Overcoming Obstacles in the Management of Uncontrolled Gout: Rapid Response From Copenhagen

Author(s)/Faculty: N. Lawrence Edwards, MD, MACP, MACR; Tuhina Neogi, MD, PhD; Pascal Richette, MD, PhD
Release Date: 6/25/2022Expiration Date: 6/24/2023
Credit Type: CMENumber of Credits: 1
Content Type: LectureProvider:
Gout is a form of inflammatory arthritis characterized by the deposition of monosodium urate crystals in the joints, tendons, and connective tissues. Uncontrolled gout (also called refractory gout or recurrent gout) is marked by serum uric acid levels that do not drop below 6 mg/dL accompanied by recurrent flares and increased tophi. Gout is associated with functional impairment and, for many, a diminished health-related quality of life. Despite major advances in treatment strategies, many patients with gout are poorly controlled or improperly managed. In this CME rapid response educational activity, an expert panel of clinicians evaluates the most recent guideline updates in the diagnosis and treatment of uncontrolled gout as well as recent trial data presented at the 2022 European Alliance of Associations for Rheumatology (EULAR) meeting, held both virtually and onsite in Copenhagen, Denmark.